Clinical Trial: A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer

U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07281976) titled 'A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer' on Dec. 02.

Brief Summary: This trial is an open-label, multicenter phase Ib/II clinical study to evaluate the efficacy and safety of LBL-024 monotherapy or in combination with albumin-bound paclitaxel in patients with recurrent or metastatic triple negative breast cancer(TNBC).

Study Start Date: Dec. 31

Study Type: INTERVENTIONAL

Condition: Triple Negative Breast Cancer

Intervention: DRUG: LBL-024 for Injection

Intravenous infusion.

DRUG: albumin-bound Paclitaxel injection

Intravenous infusion.

DRUG: Toripalimab Injection

I...